Clinical and Translational Science Institute

Centers

1-1-2018

Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence
and Risk Factors.
Sally Sultan
Columbia University

Michael Dowling
University of Texas Southwestern Medical Center at Dallas

Adam Kirton
University of Calgary

Gabrielle DeVeber
Hospital for Sick Children - Toronto

Alexandra Linds
Hospital for Sick Children - Toronto

See next page for additional authors

Follow this and additional works at: https://researchrepository.wvu.edu/ctsi
Part of the Medicine and Health Sciences Commons

Digital Commons Citation
Sultan, Sally; Dowling, Michael; Kirton, Adam; DeVeber, Gabrielle; Linds, Alexandra; and Elkind, Mitchell S.
V., "Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors." (2018). Clinical
and Translational Science Institute. 740.
https://researchrepository.wvu.edu/ctsi/740

This Article is brought to you for free and open access by the Centers at The Research Repository @ WVU. It has
been accepted for inclusion in Clinical and Translational Science Institute by an authorized administrator of The
Research Repository @ WVU. For more information, please contact ian.harmon@mail.wvu.edu.

Authors
Sally Sultan, Michael Dowling, Adam Kirton, Gabrielle DeVeber, Alexandra Linds, and Mitchell S. V. Elkind

This article is available at The Research Repository @ WVU: https://researchrepository.wvu.edu/ctsi/740

HHS Public Access
Author manuscript
Author Manuscript

Pediatr Neurol. Author manuscript; available in PMC 2019 January 01.
Published in final edited form as:
Pediatr Neurol. 2018 January ; 78: 46–54. doi:10.1016/j.pediatrneurol.2017.09.019.

Dyslipidemia in Children with Arterial Ischemic Stroke:
Prevalence and Risk Factors
Sally Sultan, MD MS1, Michael Dowling, MD PhD, MSCS2, Adam Kirton, MD, MSc3, Gabrielle
DeVeber, MD MHSc4, Alexandra Linds, MSc5, Mitchell S. V. Elkind, MD, MS6, and the IPSS
Investigators7
1Department

of Pediatrics, Columbia University Medical Center, 3959 Broadway, New York, NY

Author Manuscript

10032
2Department

of Pediatrics and Neurology & Neurotherapeutics, Division of Pediatric Neurology,
University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9063

3Calgary

Pediatric Stroke Program, Alberta Children’s Hospital Research Institute, University of
Calgary, 2888 Shaganappi Trail NW, Calgary, Alberta, Canada

4Division

of Neurology and Labatt Family Heart Centre, Department of Pediatrics, Hospital for
Sick Children, 555 University Avenue, Toronto, Ontario, Canada

5Children's

Stroke Program, The Hospital for Sick Children, The Peter Gilgan Centre for Research
and Learning, 686 Bay St. 12-9840, Toronto, ON

6Department

Author Manuscript

168th

of Neurology, College of Physicians and Surgeons, Columbia University, 710 W
Street, NI-642, New York, NY 10032

6Department

of Epidemiology, Mailman School of Public Health, Columbia University, 722 West
168th Street, New York, NY 10032

Abstract
Background—Risk factors for pediatric stroke are poorly understood and require study to
improve prevention. Total cholesterol (TC) and triglyceride (TG) values peak to near-adult levels
before puberty, a period of increased stroke incidence. The role of lipids in childhood arterial
ischemic stroke (AIS) has been minimally investigated.
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Subjects/Methods—We performed a cross-sectional analysis of lipid and Lp(a) concentrations
in children with AIS in the International Pediatric Stroke Study (IPSS) to compare the prevalence
of dyslipidemia and high or low ranking lipid values in our dataset to reported population values.
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We tested sex, BMI, race, ethnicity, family history and stroke risk factors for associations with
dyslipidemia, high non-HDL-c and hypertriglyceridemia.
Results—Compared with the National Health and Nutrition Examination Survey, a higher
proportion of children ≥5 years with AIS had dyslipidemia (38.4% vs 21%), high-TC (10.6% vs
7.4%), high non-HDL-c (23.1% vs 8.4%) and low-HDL-c (39.8% vs 13.4%). The lipid values that
corresponded to one standard deviation above the mean (84.13th%tile) in multiple published
national studies generally corresponded to a lower ranking percentile in children ≥5 years with
AIS. Dyslipidemia was more likely associated with an underweight, overweight or obese BMI
compared with a healthy weight. Ethnic background and an acute systemic illness were also
associated with abnormal lipids.
Conclusions—Dyslipidemia and hypertriglyceridemia may be more prevalent in children with
arterial ischemic stroke compared with stroke-free children.
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Introduction
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The National Heart, Lung, and Blood Institute (NHLBI) guidelines cite dyslipidemic
patterns associated with atherosclerosis in children and adults: elevated triglycerides (TG)
levels, low high-density lipoprotein cholesterol (HDL-c) levels and normal or only mildly
elevated low-density lipoprotein cholesterol (LDL-c) levels. A non-HDL-c value is the result
of subtracting HDL-c from total cholesterol (TC) and results in a combination of LDL-c,
triglyceride-rich lipoprotein cholesterol, and atherogenic lipoproteins such as intermediatedensity lipoprotein cholesterol and very-low-density lipoprotein cholesterol. In adults this
value correlates better than other lipid parameters with cardiovascular risk score and future
major cardiovascular events.(1, 2) In children the value has better correlation with
overweight and obesity than TC and LDL-c.(3, 4) In the Bogalusa Heart Study longitudinal
cohort, childhood non- HDL-c was a better predictor than LDL-c of adult dyslipidemia and
other non-lipid cardiovascular risk factors.(5) Non-HDL-c can also be accurately calculated
from nonfasted samples.
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Lipoprotein(a) (Lp(a)) reaches adult levels by the second year of life.(6) Lp(a) is an adult
cardiovascular risk factor, and data are limited for pediatric ischemic stroke.(7, 8) A recent
prospective cohort study found that baseline Lp(a) values were not higher in children with
arterial ischemic stroke (AIS) than healthy controls, and Lp(a) did not predict incident
stroke, but high Lp(a) was associated with recurrent stroke.(9)
Four factors that should be considered in childhood dyslipidemia include age, sex, body
mass index (BMI), and race. Large population surveys show a prepubertal peak in
cholesterol levels, but not triglycerides in boys. Cholesterol values are generally higher for
girls, and peak at a slightly younger age.(10–12) Children (≥5 years) and adolescents, with a
BMI >95th percentile or increased skin-fold thickness have higher dyslipidemic lipid
patterns, blood pressure and fasting insulin levels.(13–15) There is limited data regarding
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lipids in underweight children, but young underweight children may have poorer general
health and increased health care needs.(16) Lipid values v ary by race and country of origin.
Children from northern European countries including black children have similar average
lipid values whereas Asian children and black children living in Africa have lower values.
(10)

Author Manuscript

Pediatric stroke often occurs in previously healthy children and identification of risk factors
can be difficult. We have limited knowledge about the prevalence of dyslipidemia and
influence of cerebral ischemia on lipid and Lp(a) values in children with AIS. In our review
of dyslipidemia in childhood AIS, we found few studies with a healthy comparison group.
(8) The IPSS is the largest international registry of children with stroke. From this cohort
(through April 2012) we published predictors of lipid and Lp(a) testing. Compared with
children who did not have a recorded cholesterol parameter, those with recorded testing were
more likely to be older and white.(17)
Modern lifestyle, diet and environment influences pediatric health. Recent NHLBI
guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents
reflect interval data on atherosclerosis in children and adolescents and the high prevalence of
childhood obesity.(18–20) A role for early atherosclerosis and abnormal lipids in childhood
stroke would be consistent with this recent data. We hypothesized that dyslipidemia is more
prevalent in children with AIS compared with published national values. Here we compare
prevalence of dyslipidemia in children with AIS to healthy children, and we evaluate risk
factors for dyslipidemia in children with AIS.

Methods
Author Manuscript

Study Design

Author Manuscript

Baseline Characteristics

This was a cross-sectional analysis of participants in the IPSS, a prospective international
study in children and adolescents with AIS and cerebral sinus venous thrombosis (CSVT),
whose design has been described.(21)
Participants
The registry was queried from January, 2003–October, 2013 for recorded testing of at least
one cholesterol parameter: TC, HDL-c, LDL-c, TG or Lp(a). The total population with AIS
in the registry was 2 638, of whom 1 877 were children and adolescents >28 days-<19years.
Of the children and adolescents with AIS 482 (25.7%) had at least one recorded cholesterol
or Lp(a) parameter.

Data was entered by local investigators at each site into the registry. Entry of most data
points including lipids is optional. Age was analyzed as both a continuous and categorical
variable. Categorical age was defined as infancy (28 days -<2 years,) young childhood (2-<5
years,) childhood (5-<12 years,) and adolescence (12-<19 years.) For children at least 5
years old BMI was calculated and classified as a percentile and weight category by age and
sex using the Centers for Disease Control and Prevention (CDC) BMI Percentile Calculator
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for Child and Teen.(22). BMI is a valid measure for children 2 years and older, but
dyslipidemia and BMI is generally studied in children 5 years and older. The CDC defines
underweight as <5th percentile; healthy weight as the ≥5th –85th percentile; overweight as
the >85th -<95th percentile; and obesity as ≥95th percentile for age and sex.(23) Race was
defined as white, black, Asian, and other/not available. Ethnicity was defined as Hispanic or
Latino or non-Hispanic or Latino. If black, Asian or Hispanic/Latino applied to at least one
parent it was applied to the child.

Author Manuscript

All subjects had recorded testing of at least one lipid value (TC, LDL-c, HDL-c, TG) or
Lp(a). Non-HDL-c is calculated by subtracting HDL-c from TC. Lipid thresholds
recommended by the NHLBI expert panel are: high TC ≥200mg/dL, LDL-c ≥130mg/dL,
non-HDL-c ≥145mg/dL, and low HDL-c <40mg/dL. For children 0–9 years high TG were
≥100mg/dL, and for children 10–19 years, ≥130mg/dL.(18) The National Health and
Nutrition Examination Survey (NHANES) by the CDC used these thresholds.(24, 25) We
defined dyslipidemia as either TC ≥200mg/dL, or HDL-c <40mg/dL, or non-HDL-c ≥145
mg/dL. High Lp(a) was >30mg/dL because this was found to be the upper quartile threshold
value for increased risk of venous thromboembolism in childhood.(26)
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We compared the proportion of all children and children ≥5 years with abnormal values in
our study to proportions reported in two large national studies: NHANES and the Turkish
school-children study.(24, 27) Other national studies reported average values. In our sample
the lipid values were generally not normally distributed and our average values were
calculated as medians and interquartile ranges. To compare this with national samples
reporting means and standard deviations we looked at the ranking of high values identified
in national samples in our sample of children ≥ 5 years. We compared values for TC, nonHDL-c, LDL-c, TG, and Lp(a) representing the mean plus one standard deviation, the
84.13th percentile, and the value for HDL-c representing the mean minus one standard
deviation, the 15.87th percentile, from national studies to corresponding values with their
percentiles in our sample. Where there was not an exact corresponding value we estimated to
the next higher value for all lipids and Lp(a) except HDL-c where we estimated to the next
lower value. We looked to see if the high ranking values for TC, non-HDL-c, LDL-c, TG,
and Lp(a) corresponded to a lower rank in our study population ≥ 5 years and if the low
ranking HDL-c value corresponded to a higher rank. Other comparison studies included the
CASPIAN I study, the Cardiovascular Risk in Young Finn Study, the Slovak Lipid
Community Study, the Calabrian Sierras Community Study, and the Healthy Lifestyle in
Europe by Nutrition in Adolescence Cross-Sectional Study (HELENA-CSS).(28–33).
Characteristics of these studies are detailed (Table 3).
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Risk factors for AIS as defined in IPSS are: cardiac, vasculopathy, chronic disorder, acute
systemic illness, chronic head and neck disorders, and acute head and neck disorders.(34)
Stroke risk factors are not mutually exclusive. Forms of recurrence were symptomatic AIS,
silent AIS, and transient ischemic attack (TIA). A positive family history indicated that a
first or second-degree relative had a history of early (<60years) deep venous thrombosis,
stroke (ischemic or hemorrhagic), cerebral vascular disease, heart attack or pulmonary
embolus.
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For continuous variables normality was tested with the Shapiro-Wilk test. Univariate logistic
regression was used to calculate odds ratios and 95% confidence intervals for the association
of risk factors with dyslipidemia, non-HDL-c, and hypertriglyceridemia. The analysis was
performed using statistical software (SPSS 23.0, IBM).

Results

Author Manuscript

There were 482 children with AIS and at least one lipid parameter or Lp(a) included in our
analysis. The cohort was 59.8% male. Age was not normally distributed. The median age
was 6.1 (interquartile range, 8.7) years. Approximately 80% of the sample was <12 years,
and more than one third was 5-<12 years. Data was available to calculate BMI in 69.8%
(187/268) of children ≥5 years in whom 33% (62/187) were overweight or obese. More than
half of the sample was white and less than 10% were black or Asian. Only one fifth of the
sample had at least one Hispanic or Latino parent. Between 3 and 7% of the available lipids
were obtained prior to the index stroke. The majority of the analyzed lipids were obtained
after the stroke. Only 5.6% had a recurrent AIS (silent or symptomatic) or TIA. (Table 1)
Most lipid values were not normally distributed. The median lipid parameter concentrations
for the full sample and by sex do not cross abnormal thresholds but the interquartile ranges
are wide and do cross abnormal lipid thresholds. (Table 2)
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Using the same threshold values, the proportion of children with dyslipidemia was higher in
our full sample (36%), and in children ≥5 years (38.4%) compared with NHANES (21%),
where children were 6–19 years. The proportion with high non-HDL-c was similarly higher
in our full sample (19.1%), and in children ≥5 years (23.1%) compared with NHANES
(8.4%), as was the proportion with low HDL-c in our full sample (39.9%), and in children
≥5 years (39.8%) compared with NHANES (13.4%). The proportion with high TC was also
higher in our sample.
The Turkish school-children study, in children 7–18 years, used slightly higher thresholds
for abnormal non-HDL-c and TG and a slightly lower threshold for HDL-c. The proportion
of children with high non-HDL-c in our full sample (19.1%) and ≥5 years (23.1%) was
higher than Turkish school-children study (10.4%). The proportion with low HDL-c overall
(39.9%) and in children ≥5 years (39.8%) was also higher than Turkish school-children
(6.6%), and the proportion with high LDL-c was only higher in children ≥5 years (15.4%)
compared with the Turkish school-children (11.9%). The proportion with high TC was
similar in the two samples. For all lipid parameters except for Lp(a) in our sample, there was
a higher proportion of girls with abnormal values.(Table 4)

Author Manuscript

The lipid value representing the 84.13th percentile (mean +1 SD) in national studies,
corresponded to a lower percentile in our sample for 3 out of 5 studies that reported TC; for
all 3 studies reporting non-HDL-c; for 5 out of 6 studies reporting LDL-c; for all 6 studies
reporting TG; and for 2 out of 3 studies where Lp(a) was reported. The 15.87th percentile
(mean −1 SD) value for HDL-c in all 6 studies corresponded to a higher percentile in our
sample.(Table 5)
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In univariate analyses in children with AIS there were trends towards associations between
individual abnormal BMI categories and dyslipidemia, or high non-HDL-c or
hypertriglyceridemia but only when subjects categorized as having abnormal weights were
combined compared with healthy weight children did the associations have significance.
Children with either an underweight, overweight or obese BMI, compared with a healthy
weight was more likely to be associated with dyslipidemia [OR 2.2 (95%CI 1.0–4.6),
p=0.04]. High non-HDL-c (≥145 mg/dL) was more likely in children with an underweight or
obese BMI compared with healthy weight [OR 3.7 (95%CI 1.1–11.8), p=0.03], and in
children with at least one Hispanic or Latino parent [OR 2.9 (95%CI 1.1–7.7), p=0.03], and
was less likely when there was a cardiac stroke risk factor [OR 0.2 (95%CI 0.04–0.8),
p=0.03]. Hypertriglyceridemia was more likely in children with an underweight or obese
BMI compared with healthy weight [OR 4.4 (95%CI 1.2–16.4), p=0.03], in children with at
least one Hispanic or Latino parent [OR 1.9 (95%CI 1–3.8), p=0.04], and in children with an
acute systemic illness risk factor [OR 2.4 (95% CI 1.4–4.1), p=0.001]. Vasculopathy was not
associated with dyslipidemia, high non-HDL-c or hypertriglyceridemia.(data not shown)

Discussion

Author Manuscript

Dyslipidemia is well studied in other disease processes in adults and there are safe and
effective treatments. Compared to children in NHANES and Turkish school-children study,
we found a higher proportion of children with AIS to have dyslipidemia, high non-HDL-c,
and low HDL-c. The high values identified in six national studies where children were
typically ≥6 years generally corresponded to lower ranking values for TC, non-HDL-c,
LDL-c, TG and Lp(a), and the low values for HDL-c generally corresponded to a higher
rank in our sample of children ≥5 years. In this way we were able to compare high and low
ranking values in normally distributed samples to our sample. We found that the high values
for TC, non-HDL-c, LDL-c, TG and Lp(a) did not rank as high in children with AIS
implying that there is a greater representation of high values for these lipids in our sample.
Similarly the low HDL-c values in national studies ranked higher in children with AIS
implying a greater representation of low HDL-c values in our sample.

Author Manuscript

Similar to cholesterol curves by sex in healthy children, we found a higher proportion of
girls with AIS had abnormal lipid values compared with boys. Similar findings were not
seen for Lp(a). One third of children 5 years and older with available BMI data in our
sample were overweight or obese. This is similar to recently reported United States trends.
(35) Of the few risk factors that were significantly associated with dyslipidemia, high nonHDL-c or hypertriglyceridemia in our study, we found a consistent association with
underweight and obese BMI. The association between underweight BMI and dyslipidemia
has limited precedent and may imply underlying illness or inflammatory state but should be
confirmed in other samples and investigated further. Our sample had a higher than expected
proportion of underweight children (7.8%). National proportions are 3.5–5% in healthy
children and adolescents.(36) Having at least one Hispanic or Latino parent was associated
with high non-HDL-c and hypertriglyceridemia, and hypertriglyceridemia was more likely
in children with an acute systemic illness.
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Inflammation has been significantly associated with childhood AIS.(37) Inflammation
contributes to the effect of dyslipidemia in the production of atherosclerotic plaques.(38) If
these two factors interact in children to produce vascular disease we might have also
expected an association with vasculopathy but that was not found. Early in the development
of atherosclerosis, impaired vessel wall reactivity could contribute to stroke risk in children.
(39) Perhaps with higher resolution vessel wall imaging we might see more early vascular
abnormality in children with stroke.

Author Manuscript
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Our study is one of the first to compare the prevalence of dyslipidemia in a large
international childhood stroke sample with population studies. Our findings suggest further
study and identification of subgroup of children with AIS who might benefit from lipid
intervention, such as in children with underweight and obese BMI and possibly in children
with a high inflammatory state. There are a number of limitations to this study. Our sample
was small and lipid values were not normally distributed. Instead of comparing means we
could only compare percentile values in our data set with similarly ranked values from
population studies. This method is not as straightforward and intuitive as a comparison of
means. Lipids were typically measured after the stroke occurred and in order to test
dyslipidemia as a risk factor we would want prospective, uniform testing. The specific time
interval of testing from an AIS may additionally influence the lipid value. Adults who suffer
non-cerebral ischemia show an early decrease in lipid values, followed by an increase
beginning at one week and then reduced but still elevated values at 3 months.(40) In another
study the lowest values were at 2 days.(41) The data is more limited for cerebral ischemia in
adults and is not available for childhood AIS. After acute cerebral ischemia in adults one
study found no significant changes in lipid or Lp(a) levels on repeated measures within 4
weeks from stroke.(42) Serial lipid testing was not available for most of our cohort. This
limited our ability to analyze the lipids by time interval of testing from stroke.
In our cohort it is not known how decisions were made for lipid testing. Only 25% of the
eligible subjects for this study had available testing. Given this small number we previously
looked at predictors of lipid testing in this cohort and how well the tested cohort represented
the registry population. Among the predictors that we thought might influence testing,
including age, sex, race, ethnicity, BMI category, other stroke risk factors, country, US
region, and recurrent thrombosis, w e found that older age, white race, and recurrence
predicted testing. To account for that we analyzed some of these variables here as they relate
to dyslipidemia.
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We are not able to confirm the conditions of testing including whether or not these were
fasted samples. If a significant number of samples were obtained from non-fasted patients
lipid values might be falsely elevated. This is one reason that we focus here on the nonHDL-c value which can be accurately calculated from nonfasted samples. An ideal
comparison group is healthy children. Our sample did not have a stroke-free subgroup for
comparison. Instead we chose to compare our sample to published national samples. There
was some variability in the years of enrollment and age of participants among the studies.
We stratified our sample for children ≥5 years for greater symmetry with published studies
but we also included our full sample in other analyses because lipid values after the age of 2
years are thought to approximate adult values, and current screening guidelines for healthy
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children begin after this age.(43). We found that children ≥5 years were similar in proportion
with abnormal lipid values to our full sample. Future, larger samples might focus on children
≥2 years.
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In our comparison of proportions of children with abnormal values, our threshold values
were the same as the values used in NHANES, but the Turkish school-children study used
slightly higher thresholds for non-HDL-c, HDL-c, and TG. This would have an effect of
minimizing a true difference. Trending lipid values over time is best done with repeated
sampling of a cohort. Our data was generally limited to single values for participants and
each time interval represented different groups of participants. This introduces the
possibility that the differences seen with time were due to differences in the sample at each
time interval. Our sample did not well represent racial groups other than white children.
Dyslipidemia by racial and ethnic group is an important area of research in healthy children
and should be further studied in children with stroke.
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Author Manuscript

Demographics
AIS (n=482) N(%)
Male

288 (59.8)

Median age (years) at stroke(IQR)

6.1 (8.7)

Age category
infancy, 28 days- <2 yrs

114 (23.7)

young childhood, 2 - <5 yrs

100 (20.7)

childhood, 5 - <12 yrs

173 (35.9)

adolescence, 12 -<19 yrs

95 (19.7)

BMI classification by age (≥ 5years) and sex (%tiles)a
underweight, < 5th

(subjects with data)
21 (7.8)

Author Manuscript

healthy weight, ≥5th – 85th

104 (38.8)

overweight, >85th – <95th

30 (11.2)

obese, ≥95th

32 (11.9)

White

301 (62.4)

Race

Black (≥ one parent)
Asian (≥ one parent)

31 (6.4)
19 (3.9)

Other/NA (both parents)b

131 (27.2)

Non-Hispanic or Latino

383 (79.5)

Hispanic or Latino (≥ one parent)

99 (20.5)

Total cholesterol

306 (63.5)

LDL-c

176 (36.5)

HDL-c

218 (45.2)

Triglycerides

293 (60.8)

Lp(a)

237 (49.2)

Ethnicity

Author Manuscript

Lipids tested

Pre-stroke Lipid testing

(% of tested)

Total cholesterol

22 (7.2)

LDL-c

10 (5.1)

HDL-c

11 (5)

Author Manuscript

Triglycerides

16 (5.4)

Lp(a)

8 (3.1)

Follow-up Lipid Testing
Yes

18 (3.7)

Stroke Risk Factor c
Cardiac

117 (24.3)
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AIS (n=482) N(%)

Author Manuscript

Vasculopathy

137 (28.4)

Chronic disorder

136 (28.2)

Acute systemic illness

133 (27.6)

Chronic head and neck disorder
Acute head and neck disorder

40 (8.3)
103 (21.4)

Recurrence d
Any

27 (5.6)

Symptomatic AIS

18 (3.7)

Silent AIS

6 (1.2)

TIA

4 (0.8)

Family history e
Reported positive history

55 (11.4)

Author Manuscript

AIS= arterial ischemic stroke; TIA= transient ischemic attack; LDL-c= low density lipoprotein cholesterol; HDL-c= high density lipoprotein
cholesterol; Lp(a)= lipoprotein(a); IQR= interquartile range

a

CDC, (23)

b

East Indian/South Asian, First Nations/Aboriginal, Middle Eastern, Southeast Asian; NA= not available in the registry

c
Stroke risk factors are not mutually exclusive.
d

For multiple recurrences, the first is used. One patient is recorded as having a TIA and Silent AIS for their first event.

e
Family (first and second-degree relative) History of early (<60yrs) DVT, stroke (ischemic or hemorrhagic)/cerebral vascular disease/heart attack or
pulmonary embolus

Author Manuscript
Author Manuscript
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Table 2

Author Manuscript

Median Lipid Parameter Concentrations (mg/dL)
overall [median (IQR, N)]
boys
Total cholesterol

girls

156 (51.3, 306)
147 (54, 185)

non-HDL-c

111 (43, 204)
105 (43.9, 116)

LDL-c

42 (17, 93)

Author Manuscript

91 (82, 293)
90 (80.3, 170)

Lp(a)

93 (42, 83)

44 (20, 218)
46 (22, 125)

Triglycerides

118.5 (45, 88)

88.5 (39.8, 196)
83 (39.5, 113)

HDL-c

160 (49, 121)

95 (84, 123)

10 (20, 237)
10 (21, 139)

8 (20, 98)

LDL-c= low density lipoprotein cholesterol; HDL-c= high density lipoprotein cholesterol; Lp(a)= lipoprotein(a); IQR= interquartile range

Author Manuscript
Author Manuscript
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Author Manuscript

Author Manuscript
average values 2007–
2010a proportions
2011–2014b

1980
10/2005–1/2007
published in 2013
published in 2012

cross sectional

cross-sectional
population-based sample
population-based prospective cohort
cross-sectional biracial
cohort sample
multicenter cross-sectional

National Health and
Nutrition Examination
Survey cross sectional
analysisa,b

Turkish school-childrenc

CASPIAN I studyd

Young Finns Studyf

Slovak Lipid Community
Studyg,h

Calabrian Sierras
Community StudyI

European adolescents HELENA Studyj

(24)
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2003–2004

10 European centers

Southern Italy (14town community)

Central Slovakia

Finland

Iran

Eskisehir, Turkey

United States

international

Location of
study

(32)

I

Lp(a) study (31)

h

(30);

(29)

g

f

e
Lipid Research Clinic standards, Nelson Textbook of Pediatrics 17th edn. Saunders, Philadelphia, pp 445–459

(28);

d

(27)

c

b

(25)

a

2003–2013

cross sectional

present study

published in 2007

Years of enrolment
(or publication year)

Study Design

12.5–17.5

6–14

7–17; non-HDL-c 7–
11; Lp(a) study 7–18

3–15

6–18

7–18

6–19 (TG 12–19)

28 days - < 19

Age of
participants
(years)

Author Manuscript

Comparative features of present study and population studies

summary values and percentile distribution of
this sample

age and sex specific 95th percentileof this
sample

summary values only

NCEP for cholesterol (1992)(1741227); AAP
and AHA guidelines for TG (2003)(12654618)

age and gender-specific 95th %tile of LRC
standardse, HDL-C < 5th percentile

TC >200; LDL-c >130; non-HDL-C > 150;
HDL-c <35; TG >140

TC ≥200; LDL-c ≥130; non- HDL-c ≥145;
HDL-c <40; TG ≥100 (0–9 years) and ≥130
(10–19 years)

TC ≥200; LDL-c ≥130; non- HDL-c ≥145;
HDL-c <40; TG ≥100 (0–9 years) and ≥130
(10–19 years)

Threshold values (mg/dL)

Author Manuscript
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j

(33)
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Author Manuscript

Pediatr Neurol. Author manuscript; available in PMC 2019 January 01.
42.4 (53/125)

11.6 (14/121)

22.7 (20/88)

14.5 (12/83)

43 (40/93)

47.2 (42/89)

35.3 (12/34)

20.9 (29/139)

19.4 (19/98)

20.3 (48/237)

31.3(15/48)

32.9 (27/82)

42.6 (52/122)

44.5 (94/211)

37.6 (47/125)

39.9 (87/218)

8 (9/113)

10.7 (21/196)

16.4 (19/116)

19.1 (39/204)

10.3 (19/185)

10.8 (33/306)

32 (62/194)

36 (115/319)

girls

45.9 (34/74)

11.1 (8/72)

27.3 (15/55)

21.2 (11/52)

43.9 (25/57)

40.6 (13/32)

35.3 (12/34)

28.7 (22/79)

20 (13/65)

24.3 (35/144)

31.3(15/48)

32.9 (27/82)

40.5 (15/37)

40.6 (28/69)

36.6 (26/71)

39.8 (51/128)

10.8 (7/65)

15.4 (18/117)

19.7 (13/66)

23.1 (28/121)

10.2 (10/98)

10.6 (18/170)

33 (34/103)

38.4 (68/177)

boys

8.4

7.4

21

12

9.4

8.9

21

girls

13.4
14.8

7.5

5.9

20.9

boys

overall

National
Health and
Nutrition
Examination
Surveyb
(n=4638)(%)

8.1

5.5

9.1

7.5

6.6

8.9

7.7

14.5

11.9

8.9

14.1
10.4

13.2

9.5

girls

11.8

boys

overall

Turkish
schoolchildrenc
(n= 2896)
(%)

(24)

(27)

c

significant

TC ≥200mg/dL or HDL-c <40mg/dL or non-HDL-c ≥145 mg/dL

b

a

*

TC= total cholesterol; HDL-c= high density lipoprotein cholesterol; LDL-c= low density lipoprotein cholesterol; TG= triglycerides; Lp(a)= lipoprotein(a)

Lp(a): abn high (>30mg/dL)

High TG, 10- <19 yrs (≥130mg/dL)

High TG, 0- <10 yrs (≥100mg/dL)

Low HDL-c (<40mg/dL)

High LDL-c (≥130 mg/dL)

High non- HDL-c (≥145 mg/dL)

High TC (≥200mg/dL)

Dyslipidemiaa

girls

overall

overall
boys

AIS ≥5 years (%) (n/n)

AIS (%) (n/n)

Proportion with lipid or Lp(a) abnormality in our study and representative population-based studies

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript
Lp(a)

TG

HDL-c

128.2
68.2*

71.8*

36.8*

31*
125.6

38.2

78.8*

83.1*
37.6

128

80*

78.8*
118.1

147

90.3

86.7
136.9

199.9

189.7

Females

Young Finns
Studyd

Slovak Lipid Community
Studye,f

Calabrian
Sierras
Community
Studyg

65.6*

118

18*

31.8

77.8*

115.4

54.1*

93

59.2*

48

>98.5

152.7

56.1*

100.1

73.7*

49.1

96.2

160.9

65.2*

Females

38.8
78.5*
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(29)

e
(30);

d

c
(28)

(27)

b

Corresponding percentile in our study is lesser than 84.13%tile for TC, non-HDL-c, LDL-c, TG, and Lp(a), or greater than 15.87%tile for HDL-c 525

*

a
For TC, non-HDL-c, LDL-c, TG, and Lp(a), mean + 1SD = 84.13th percentile; for HDL-c, mean - 1SD= 15.87th percentile

57.6*

97

42.3*

43

81.5*

114

77.6*

179

81.9*

51*

90

39.8*

39

77.8*

116

68.6*

132

78.2*

184

Males

89.2

46.4

63.6*

112

68.4*

46

75*

123

84.7

195

Females

European
adolescents HELENA Studyh

39.9

68.9*

127.5

18.8*

32.5

74.4*

61.8*

75th%tile, 130.7

108.3

75th%tile, 116.4

72.9*

78.2*

Males
175.2

Females

182.7

Males

Mean+ 1SD (84.13th %tile), [Mean-1SD for HDL-c (15.87th %tile)] (mg/dL)a

CASPIAN
I studyc

SD= standard deviation; TC= total cholesterol; HDL-c= high density lipoprotein cholesterol; LDL-c= low density lipoprotein cholesterol; TG= triglycerides; Lp(a)= lipoprotein(a)

Corresponding percentile of the value among
similar children with AIS ≥ 5 years in our
study (%tile)

LDL-c

nonHDL-c

TC

Males

Turkish schoolchildrenb

Comparison of values representing a fixed percentile in published national values to the percentile of the corresponding value among children with AIS ≥
5 years
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h

(32)

g

f

Author Manuscript

Lp(a) study (31)
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